Skip to main content
Fig. 3 | BMC Medical Research Methodology

Fig. 3

From: Evaluation of a multi-arm multi-stage Bayesian design for phase II drug selection trials – an example in hemato-oncology

Fig. 3

Results of the MDS trial- Bayesian analyses using non-informative uniform priors, the minimum required treatment response rate at MRT=0.3 (Rule 1), the targeted minimal response rate at Δ=0 (Rule 2), and a sufficient treatment response rate at STR=0.15 (Rule 3), with the cut-off probability thresholds for rules 1–3 set at 0.9, 0.1 and 0.9, respectively

Back to article page

BMC Medical Research Methodology

ISSN: 1471-2288

Contact us